Abg Innovation Capital Partners Iii Gp LTD Pulmonx Corp Transaction History

Abg Innovation Capital Partners Iii Gp LTD

$837,000
Q2 2024

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$21.13 - $35.65 $61,298 - $103,420	-2,901 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$29.72 - $45.1 $48,146 - $73,062	-1,620 Reduced 35.83%	2,901 $93,000
Q2 2021 Aug 16, 2021	SELL	$37.61 - $48.0 $31.2 Million - $39.8 Million	-828,812 Reduced 99.46%	4,521 $199,000
Q4 2020 Feb 16, 2021	BUY	$39.31 - $69.02 $32.8 Million - $57.5 Million	833,333 New	833,333 $57.5 Million

Others Institutions Holding LUNG

# of Institutions

118

Shares Held

30.6M

Call Options Held

400

Put Options Held

Primecap Management CO Pasadena, CA

5.71M
Shares

$35.8 Million
0.03% of portfolio
Morgan Stanley New York, NY

3.47M
Shares

$21.8 Million
0.0% of portfolio
Black Rock Inc. New York, NY

2.67M
Shares

$16.7 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

2.18M
Shares

$13.6 Million
0.0% of portfolio
Deutsche Bank Ag\ Frankfurt Am Main, 2M

1.29M
Shares

$8.11 Million
0.0% of portfolio

View Full List

About Pulmonx Corp

Ticker LUNG
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 37,268,400
Market Cap $234M
Description
Pulmonx Corporation, a medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. It offers Zephyr Endobronchial Valve, a solution for the treatment of bronchoscopic in adult patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a ...

More about LUNG

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Abg Innovation Capital Partners Iii Gp LTD, based on Form 13F filings with the SEC.

News

Stay updated on Abg Innovation Capital Partners Iii Gp LTD with notifications on news.

Account